etanidazole has been researched along with Bone Loss, Osteoclastic in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurowska-Stolarska, M | 1 |
| Distler, JH | 1 |
| Jüngel, A | 1 |
| Rudnicka, W | 1 |
| Neumann, E | 1 |
| Pap, T | 1 |
| Wenger, RH | 1 |
| Michel, BA | 1 |
| Müller-Ladner, U | 1 |
| Gay, RE | 1 |
| Maslinski, W | 1 |
| Gay, S | 1 |
| Distler, O | 1 |
1 other study available for etanidazole and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis.
Topics: Animals; Arthritis, Experimental; Bone Resorption; Cell Hypoxia; Etanidazole; Fibroblasts; Humans; H | 2009 |